Industrial material specialist Morgan Crucible's markets have been hit hard by the downturn. Last week's first-half results were reassuring and though the company does have a significant amount of debt - and there had been worries that a rights issue would be needed to shore up its balance sheet - a cash call now looks unlikely. The shares are trading on a December 2009 earnings multiple of 9.6 times and yielding a respectable 5%. The shares are a buy at this level says the Sunday Telegraph.BAE Systems is trading on a December 2009 earnings multiple of 7.6, which appears derisory for such a company. The shares are down by 10% since November last year - but the Sunday Telegraph's upbeat stance is unchanged. The shares are yielding a solid 5% and are a buy.Sugar and sweetener group Tate & Lyle has had a roller coaster year - and the shares plunged after a series of warnings and the loss of a patent case. The share price has continued to recover recently, but yielding 6.3% the shares remain a buy at this level says the Sunday Telegraph.International Ferro Metals has been through a rough patch, but it is almost certainly over the worst. Over the next few years, Chinese appetite for stainless steel is expected to grow at a rapid pace and IFM is well placed to benefit, thanks to contacts built up over many years. The company also remains a leading supplier to European and US stainless steel manufacturers. Even conservative brokers believe the shares should almost double in price over the coming year. Buy and hold says the Mail on Sunday.It is unusual to find a small pharmaceutical company that is profitable and has money in the bank, but IS Pharma is one such business, says the Mail on Sunday. IS Pharma is valued on the stock market at £25m. Investors who bought in November should stick with it. New investors may be tempted to buy a few shares and see if the company can achieve its high ambitions.Please note: Digital Look provides a round-up of news, tips and information that is impacting share prices and the market. Digital Look cannot take any responsibility for information provided by third parties. This is for your general information only as not intended to be relied upon by users in making an investment decision or any other decision. Please obtain a copy of the relevant publication and carry out your own research before considering acting on any of this information.